Feline herpesvirus

Veterinary Research

Volumn 38, Issue 2, 2007, Pages 337-354

  Gaskell, Rosalind ^a   Dawson, Susan ^a   Radford, Alan ^a   Thiry, Etienne ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Epidemiology; Feline herpesvirus; Pathogenesis; Review

Indexed keywords

ACICLOVIR; ADJUVANT; ALUMINUM; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BROMHEXINE; CIDOFOVIR; GANCICLOVIR; HERPES SIMPLEX VACCINE; IDOXURIDINE; INACTIVATED VACCINE; INTERFERON; LACTOFERRIN; LIVE VACCINE; LYSINE; NUCLEOSIDE ANALOG; OMEGA INTERFERON; PHENYLEPHRINE; RECOMBINANT ALPHA INTERFERON; TRIFLURIDINE; UNCLASSIFIED DRUG; VALACICLOVIR; VIDARABINE; VIRUS VACCINE;

ANIMAL HUSBANDRY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CAT; CAT DISEASE; CLINICAL FEATURE; CONJUNCTIVITIS; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; EPIDEMIOLOGICAL DATA; EYE DISEASE; FLUID THERAPY; GENETIC ENGINEERING; HERPES SIMPLEX VIRUS 1; HERPES VIRUS INFECTION; HOUSEHOLD; IMMUNITY; INFECTION CONTROL; INFECTION PREVENTION; INJECTION SITE REACTION; KERATITIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; SARCOMA; SEROTYPE; SKIN DISEASE; TRIGEMINUS GANGLION; VACCINATION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS SHEDDING;

ALPHAHERPESVIRINAE; ANIMALS; CAT DISEASES; CATS; HERPESVIRIDAE INFECTIONS;

CANID HERPESVIRUS 1; FELID HERPESVIRUS 1; HUMAN HERPESVIRUS 1;

EID: 34147190735     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres:2006063     Document Type: Review

References (159)

1. Bannasch M.J., Foley J.E., Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters, J. Feline Med. Surg. (2005) 7:109-119.
2. Beaumont S.L., Maggs D.J., Clarke H.E., Effects of bovine lactoferrin on in vitro replication of feline herpesvirus, Vet. Ophthalmol. (2003) 6:245-250.
3. Binns S.H., Dawson S., Speakman A.J., Cuevas L.E., Hart C.A., Gaskell C.J., Morgan K.L., Gaskell R.M., A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus, J. Feline Med. Surg. (2000) 2:123-133.
4. Bistner S.I., Carlson J.H., Shively J.N., Scott F.W., Ocular manifestations of feline herpesvirus infection, J. Am. Vet. Med. Assoc. (1971) 159:1223-1237.
5. Bittle J.L., Peckham J.C., Genital infection induced by feline rhinotracheitis virus and effects on newborn kittens, J. Am. Vet. Med. Assoc. (1971) 158 (Suppl. 2):927-928.
6. Bittle J.L., Rubic W.J., Studies of feline viral rhinotracheitis vaccine, Vet. Med. Small Anim. Clin. (1974) 69:1503-1505.
7. Bosch J.C., Kaashoek M.J., van Oirschot J.T., Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine, Vaccine (1997) 15:1512-1517.
8. Burgesser K.M., Hotaling S., Schiebel A., Ashbaugh S.E., Roberts S.M., Collins J.K., Comparison of PCR, virus isolation, and indirect fluorescent antibody staining in the detection of naturally occurring feline herpesvirus infections, J. Vet. Diagn. Invest. (1999) 11:122-126.
9. Carlson J.H., Scott F.W., An immunofluorescence diagnostic test for feline viral rhinotracheitis, Am. J. Vet. Res. (1978) 39:465-467.
10. Cocker F.M., Gaskell R.M., Newby T.J., Gaskell C.J., Stokes C.R., Bourne F.J., Efficacy of early (48 and 96 h) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant, Vet. Rec. (1984) 114:353-354.
11. Cocker F.M., Newby T.J., Gaskell R.M., Evans P.A., Gaskell C.J., Stokes C.R., Harbour D.A., Bourne J.F., Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1, Res. Vet. Sci. (1986) 41:323-330.
12. Cole G.E., Stacy-Phipps S., Nunberg J.H., Recombinant feline herpesviruses expressing feline leukemia virus envelope and gag proteins, J. Virol. (1990) 64:4930-4938.
13. Collins B.K., Treatment of feline ocular herpesvirus infections: a review, Adv. Small Anim. Med. Surg. (2002) 15:1-3.
14. Crandell R.A., Rehkemper J.A., Niemann W.H., Ganaway J.R., Maurer F.D., Experimental feline viral rhinotracheitis, J. Am. Vet. Med. Assoc. (1961) 138:191-196.
15. Crandell R.A., Feline viral rhinotracheitis (FVR), Adv. Vet. Sci. Comp. Med. (1973) 17:201-224.
16. Daniels M.J., Golder M.C., Jarrett O., MacDonald D.W., Feline viruses in wildcats from Scotland, J. Wildl. Dis. (1999) 35:121-124.
17. Davison A.J., Seberle R., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E., Herpesviridae, in: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., Ball L.A. (Eds.), Virus Taxonomy: Eighth report of the International Committee on Taxonomy of Viruses, Elsevier, San Diego, 2005, pp. 193-212.
18. Dawson S., Willoughby K., Gaskell R.M., Wood G., Chalmers W.S., A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens, J. Feline Med. Surg. (2001) 3:17-22.
19. De Mari K., Maynard L., Sanquer A., Lebreux B., Eun H.M., Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats, J. Vet. Intern. Med. (2004) 18:477-482.
20. Donaldson A.I., Ferris N.P., The survival of some air-borne animal viruses in relation to relative humidity, Vet. Microbiol. (1976) 1:413-420.
21. Edinboro C.H., Janowitz L.K., Guptill-Yoran L., A clinical trial of intranasal and subcutaneous vaccines to prevent upper respiratory infection in cats at animal shelter, Feline Pract. (1999) 27:7-13.
22. Eleraky N.Z., Potgieter L.N., Kennedy M.A., Virucidal efficacy of four new disinfectants, J. Am. Anim. Hosp. Assoc. (2002) 38:231-234.
23. Ellis T.M., Feline respiratory virus carriers in clinically healthy cats, Aust. Vet. J. (1981) 57:115-118.
24. Evermann J.F., McKeirnan A.J., Ott R.L., Reed L.A., Diarrheal condition in dogs associated with viruses antigenically related to feline herpesvirus, Cornell Vet. (1982) 72:285-291.
25. Evermann J.F., Laurenson M., McKeirnan A.J., Caro T.M., Infectious disease surveillance in captive and free-living cheetahs - an integral part of the species survival plan, Zoo Biol. (1993) 12:125-133.
26. Flecknell P.A., Orr C.M., Wright A.I., Gaskell R.M., Kelly D.F., Skin ulceration associated with herpesvirus infection in cats, Vet. Rec. (1979) 104:313-315.
27. Fulton R.W., Burge L.J., Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons, Antimicrob. Agents Chemother. (1985) 28:698-699.
28. Gaskell R., Willoughby K., Herpesviruses of carnivores, Vet. Microbiol. (1999) 69:73-88.
29. Gaskell R.M., Povey R.C., Re-excretion of feline viral rhinotracheitis virus following corticosteroid treatment, Vet. Rec. (1973) 93:204-205.
30. Gaskell R.M., Povey R.C., Experimental induction of feline viral rhinotracheitis (FVR) virus re-excretion in FVR-recovered cats, Vet. Rec. (1977) 100:128-133.
31. Gaskell R.M., Wardley R.C., Feline viral respiratory disease: a review with particular reference to its epizootiology and control, J. Small Anim. Pract. (1978) 19:1-16.
32. Gaskell R.M., Povey R.C., Feline viral rhinotracheitis: sites of virus replication and persistence in acutely and persistently infected cats, Res. Vet. Sci. (1979) 27:167-174.
33. Gaskell R.M., Povey R.C., The dose response of cats to experimental infection with feline viral rhinotracheitis virus, J. Comp. Pathol. (1979) 89:179-191.
34. Gaskell R.M., Povey R.C., Transmission of feline viral rhinotracheitis, Vet. Rec. (1982) 111:359-362.
35. Gaskell R.M., Dennis P.E., Goddard L.E., Cocker F.M., Wills J.M., Isolation of felid herpesvirus 1 from the trigeminal ganglia of latently infected cells, J. Gen. Virol. (1985) 66:391-394.
36. Gaskell R.M., Dawson S., Viral-induced upper respiratory tract disease, in: Chandler E.A., Gaskell C.J., Gaskell R.M. (Eds.), Feline Medicine and Therapeutics, Blackwell Scientific Publications, Oxford, 1994, pp. 453-472.
37. Gaskell R.M., Gettinby G., Graham S.J., Skilton D., Veterinary Products Committee (VPC) working group report on feline and canine vaccination, Final report to the VPC, Departmental for Environmental, Food and Rural Affairs, London, 2002.
38. Gaskell R.M., Gettinby G., Graham S.J., Skilton D., Veterinary Products Committee working group report on feline and canine vaccination, Vet. Rec. (2002) 150:126-134.
39. Gaskell R.M., Radford A.D., Dawson S., Feline infectious respiratory disease, in: Chandler E.A., Gaskell C.J., Gaskell R.M. (Eds.), Feline medicine and therapeutics, Blackwell Publishing, 2004, pp. 577-595.
40. Goddard L.E., Immunological studies during acute and latent felid herpesvirus 1 infection, Ph.D. thesis, University of Bristol, 1984.
41. Grail A., Harbour D.A., Restriction endonuclease analysis of DNA from isolates of feline herpesvirus type 1, Jpn. J. Vet. Sci. (1990) 52:1007-1013.
42. Hamano M., Maeda K., Mizukoshi F., Une Y., Mochizuki M., Tohya Y., Akashi H., Kai K., Experimental infection of recent field isolates of feline herpesvirus type 1, J. Vet. Med. Sci. (2003) 65:939-943.
43. Hamano M., Maeda K., Mizukoshi F., Mochizuki M., Tohya Y., Akashi H., Kai K., Genetic rearrangements in the gC gene of the feline herpesvirus type 1, Virus Genes (2004) 28:55-60.
44. Hamano M., Maeda K., Kai K., Mochizuki M., Tohya Y., Akashi H., A novel genetic marker to differentiate feline herpesvirus type 1 field isolates, Vet. Microbiol. (2005) 106:195-200.
45. Hara M., Fukuyama M., Suzuki Y., Kisikawa S., Ikeda T., Kiuchi A., Tabuchi K., Detection of feline herpesvirus 1 DNA by the nested polymerase chain reaction, Vet. Microbiol. (1996) 48:345-352.
46. Harder T.C., Harder M., Vos H., Kulonen K., Kennedy-Stoskopf S., Liess B., Appel M.J., Osterhaus A.D., Characterization of phocid herpesvirus-1 and -2 as putative alpha- and gammaherpesviruses of North American and European pinnipeds, J. Gen. Virol. (1996) 77:27-35.
47. Harder T.C., Harder M., de Swart R.L., Osterhaus A.D.M.E., Leiss B., Major immunogenic proteins of phocid herpesviruses and their relationships to proteins of canine and feline herpesviruses, Vet. Q. (1997) 20:50-55.
48. Harder T.C., Osterhaus A.D., Molecular characterization and baculovirus expression of the glycoprotein B of a seal herpesvirus (phocid herpesvirus-1), Virology (1997) 227:343-352.
49. Hargis A.M., Ginn P.E., Feline herpesvirus 1-associated facial and nasal dermatitis and stomatitis in domestic cats, Vet. Clin. North Am. Small Anim. Pract. (1999) 29:1281-1290.
50. Hargis A.M., Ginn P.E., Mansell J.E.K.L., Garber R.L., Ulcerative facial and nasal dermatitis and stomatitis in cats associated with feline herpesvirus 1, Vet. Dermatol. (1999)10:267-274.
51. Helps C.R., Lait P., Damhuis A., Bjornehammar U., Bolta D., Brovida C., Chabanne L., Egberink H., Ferrand G., Fontbonne A., Pennisi M.G., Gruffydd-Jones T., Gunn-Moore D., Hartmann K., Lutz H., Malandain E., Mostl K., Stengel C., Harbour D.A., Graat E.A., Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries, Vet. Rec. (2005) 156:669-673.
52. Herrmann S.-C., Gaskell R.M., Ehlers B., Ludwig H., Characterization of the feline herpesvirus genome and molecular epidemiology of isolates from natural outbreaks and latent infections, in: Wittmann G., Gaskell R.M., Rziha H.-J. (Eds.), Latent herpesvirus infections in veterinary medicine, Martinus Nijhoff, 1984, pp. 321-336.
53. Hickman M.A., Reubel G.H., Hoffman D.E., Morris J.G., Rogers Q.R., Pedersen N.C., An epizootic of feline herpesvirus, type 1 in a large specific pathogen-free cat colony and attempts to eradicate the infection by identification and culling of carriers, Lab. Anim. (1994) 28:320-329.
54. Hofmann-Lehmann R., Fehr D., Grob M., Elgizoli M., Packer C., Martenson J.S., O'Brien S.J., Lutz H., Prevalence of antibodies to feline parvovirus, calicivirus, herpesvirus, coronavirus, and immunodeficiency virus and of feline leukemia virus antigen and the interrelationship of these viral infections in free-ranging lions in east Africa, Clin. Diagn. Lab. Immunol. (1996) 3:554-562.
55. Holland J.L., Outerbridge C.A., Affolter V.K., Maggs D.J., Detection of feline herpesvirus 1 DNA in skin biopsy specimens from cats with or without dermatitis, J. Am. Vet. Med. Assoc. (2006) 229:1442-1446.
56. Hoover E.A., Rohovsky M.W., Griesemer R.A., Experimental feline viral rhinotracheitis in the germfree cat, Am. J. Pathol. (1970) 58:269-282.
57. Hoover E.A., Griesemer R.A., Bone lesions produced by feline herpesvirus, Lab. Invest. (1971) 25:457-464.
58. Hoover E.A., Griesemer R.A., Experimental feline herpesvirus infection in the pregnant cat, Am. J. Pathol. (1971) 65:173-188.
59. Horimoto T., Limcumpao J.A., Xuan X., Ono M., Maeda K., Kawaguchi Y., Kai C., Takahashi E., Mikami T., Heterogeneity of feline herpesvirus type 1 strains, Arch. Virol. (1992) 126:283-292.
60. Iglauer F., Gartner K., Morstedt R., Maternal protection against feline respiratory disease by means of booster vaccinations during pregnancy - a retrospective clinical study, Kleintierpraxis (1989) 34:235.
61. Johnson L.R., Foley J.E., De Cock H.E., Clarke H.E., Maggs D.J., Assessment of infectious organisms associated with chronic rhinosinusitis in cats, J. Am. Vet. Med. Assoc. (2005) 227:579-585.
62. Johnson L.R., Maggs D.J., Feline herpesvirus type-1 transcription is associated with increased nasal cytokine gene transcription in cats, Vet. Microbiol. (2005) 108:225-233.
63. Johnson R.P., Sabine M., The isolation of herpesviruses from skin ulcers in domestic cats, Vet. Rec. (1971) 89:360-362.
64. Johnson R.P., Povey R.C., Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies, J. Am. Vet. Med. Assoc. (1985) 186:149-152.
65. Junge R.E., Miller R.E., Boever W.J., Scherba G., Sundberg J., Persistent cutaneous ulcers associated with feline herpesvirus type 1 infection in a cheetah, J. Am. Vet. Med. Assoc. (1991) 198:1057-1058.
66. Knowles J.O., Gaskell R.M., Gaskell C.J., Harvey C.E., Lutz H., Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis, Vet. Rec. (1989) 124:336-338.
67. Kramer J.W., Evermann J.F., Leathers C.W., McKeirnan A.J., Rashti L., Experimental infection of two dogs with a canine isolate of feline herpesvirus type 1, Vet. Pathol. (1991) 28:338-340.
68. Kruger J.M., Sussman M.D., Maes R.K., Glycoproteins gl and gE of feline herpesvirus-1 are virulence genes: safety and efficacy of a gl-gE deletion mutant in the natural host, Virology (1996) 220:299-308.
69. Lappin M.R., Andrews J., Simpson D., Jensen W.A., Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats, J. Am. Vet. Med. Assoc. (2002) 220:38-42.
70. Lappin M.R., Sebring R.W., Porter M., Radecki S.J., Veir J., Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1, J. Feline Med. Surg. (2006) 8:158-163.
71. Lebich M., Harder T.C., Frey H.R., Visser I.K., Osterhaus A.D., Liess B., Comparative immunological characterization of type-specific and conserved B-cell epitopes of pinniped, felid and canid herpesviruses, Arch. Virol. (1994) 136:335-347.
72. Levy J.K., Reese M.J., Patterson E.V., Tucker S.J., The effect of anesthesia and surgery on serological responses to vaccination in kittens, J. Vet. Intern. Med. (2006) 20:759.
73. Lommer M.J., Verstraete F.J., Concurrent oral shedding of feline calicivirus and feline herpesvirus 1 in cats with chronic gingivostomatitis, Oral Microbiol. Immunol. (2003) 18:131-134.
74. Love D.N., Feline herpesvirus associated with interstitial pneumonia in a kitten, Vet. Rec. (1971) 89:178-181.
75. Macy D.W., Current understanding of vaccination site-associated sarcomas in the cat, J. Feline Med. Surg. (1999) 1:15-21.
76. Maeda K., Kawaguchi Y., Ono M., Tajima T., Mikami T., Restriction endonuclease analysis of field isolates of feline herpesvirus type 1 and identification of heterogeneous regions, J. Clin. Microbiol. (1995) 33:217-221.
77. Maeda K., Ono M., Kawaguchi Y., Niikura M., Okazaki K., Yokoyama N., Tokiyoshi Y., Tohya Y., Mikami T., Expression and properties of feline herpesvirus type 1 gD (hemagglutinin) by a recombinant baculovirus, Virus Res. (1996) 46:75-80.
78. Maggs D.J., Lappin M.R., Nasisse M.P., Detection of feline herpesvirus-specific antibodies and DNA in aqueous humor from cats with or without uveitis, Am. J. Vet. Res. (1999) 60:932-936.
79. Maggs D.J., Collins B.K., Thorne J.G., Nasisse M.P., Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1, Am. J. Vet. Res. (2000) 61:1474-1478.
80. Maggs D.J., Nasisse M.P., Kass P.H., Efficacy of oral supplementation with L-lysine in cats latently infected with feline herpesvirus, Am. J. Vet. Res. (2003) 64:37-42.
81. Maggs D.J., Clarke H.E., In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1, Am. J. Vet. Res. (2004) 65:399-403.
82. Maggs D.J., Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1, Clin. Tech. Small Anim. Pract. (2005) 20:94-101.
83. Maggs D.J., Clarke H.E., Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines, Am. J. Vet. Res. (2005) 66:1550-1555.
84. Maggs D.J., Sykes J.E., Clarke H.E., Yoo S.H., Kass P.H., Lappin M.R., Rogers Q.R., Waldron M.K., Fascetti A.J., Effects of dietary lysine supplementation in cats with enzootic upper respiratory disease, J. Feline Med. Surg. (2006) doi:10.1016/jms.2006.08.005.
85. Martina B.E., Airikkala M.I., Harder T.C., van Amerongen G., Osterhaus A.D., A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection, Vaccine (2001) 20:943-948.
86. Martina B.E., Harder T.C., Osterhaus A.D., Genetic characterization of the unique short segment of phocid herpesvirus type 1 reveals close relationships among alphaherpesviruses of hosts of the order Carnivora, J. Gen. Virol. (2003) 84:1427-1430.
87. Martina B.E., van de Bildt M.W., Kuiken T., van Amerongen G., Osterhaus A.D., Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1, Vaccine (2003) 21:2433-2440.
88. Mishima M., Xuan X., Nishikawa Y., Makala L., Yokoyama N., Nagasawa H., Mikami T., Construction of recombinant feline herpesvirus type 1 expressing Toxoplasma gondii surface antigen 1, Mol. Biochem. Parasitol. (2001) 117:103-106.
89. Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., Mikami T., Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats, Parasitol. Res. (2002) 88:144-149.
90. Morrison W.B., Starr R.M., Vaccine-associated feline sarcomas, J. Am. Vet. Med. Assoc. (2001) 218:697-702.
91. Munson L., Wack R., Duncan M., Montali R.J., Boon D., Stalis I., Crawshaw G.J., Cameron K.N., Mortenson J., Citino S., Zuba J., Junge R.E., Chronic eosinophilic dermatitis associated with persistent feline herpes virus infection in cheetahs (Acinonyx jubatus), Vet. Pathol. (2004) 41:170-176.
92. Nasisse M.P., Guy J.S., Davidson M.G., Sussman W., De Clercq E., In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine, Am. J. Vet. Res. (1989) 50:158-160.
93. Nasisse M.P., Guy J.S., Davidson M.G., Sussmann W.A., Fairley N.M., Experimental occular herpesvirus infection in the cat. Sites of virus replication, clinical features and effects of corticosteroid administration, Invest. Ophthalmol. Visual Sci. (1989) 30:1758-1768.
94. Nasisse M.P., Davis B.J., Guy J.S., Davidson M.G., Sussman W., Isolation of feline herpesvirus 1 from the trigeminal ganglia of acutely and chronically infected cats, J. Vet. Intern. Med. (1992) 6:102-103.
95. Nasisse M.P., English R.V., Tompkins M.B., Guy J.S., Sussman W., Immunologic, histologic, and virologic features of herpesvirus-induced stromal keratitis in cats, Am. J. Vet. Res. (1995) 56:51-55.
96. Nasisse M.P., Dorman D.C., Jamison K.C., Weigler B.J., Hawkins E.C., Stevens J.B., Effects of valacyclovir in cats infected with feline herpesvirus 1, Am. J. Vet. Res. (1997) 58:1141-1144.
97. Nasisse M.P., Glover T.L., Moore C.P., Weigler B.J., Detection of feline herpesvirus 1 DNA in corneas of cats with eosinophilic keratitis or corneal sequestration, Am. J. Vet. Res. (1998) 59:856-858.
98. Ohmura Y., Ono E., Matsuura T., Kida H., Shimizu Y., Detection of feline herpesvirus 1 transcripts in trigeminal ganglia of latently infected cats, Arch. Virol. (1993) 129:341-347.
99. Orr C.M., Gaskell C.J., Gaskell R.M., Interaction of a combined feline viral rhinotracheitis-feline calicivirus vaccine and the FVR carrier state, Vet. Rec. (1978) 103:200-202.
100. Orr C.M., Gaskell C.J., Gaskell R.M., Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state, Vet. Rec. (1980) 106:164-166.
101. Ostrowski S., Van Vuuren M., Lenain D.M., Durand A., A serologic survey of wild felids from central west Saudi Arabia, J. Wildl. Dis. (2003) 39:696-701.
102. Owens J.G., Nasisse M.P., Tadepalli S.M., Dorman D.C., Pharmacokinetics of acyclovir in the cat, J. Vet. Pharmacol. Ther. (1996) 19:488-490.
103. Paul-Murphy J., Work T., Hunter D., McFie E., Fjelline D., Serologic survey and serum biochemical reference ranges of the free-ranging mountain lion (Felis concolor) in California, J. Wildl. Dis. (1994) 30:205-215.
104. Pedersen N.C., Sato R., Foley J.E., Poland A.M., Common virus infections in cats, before and after being placed in shelters, with emphasis on feline enteric coronavirus, J. Feline Med. Surg. (2004) 6:83-88.
105. Povey R.C., Johnson R.H., Observations on the epidemiology and control of viral respiratory disease in cats, J. Small Anim. Pract. (1970) 11:485-494.
106. Povey R.C., Feline respiratory disease - which vaccine? Feline Pract. (1977) 7:12-16.
107. Povey R.C., Wilson M.R., A comparison of inactivated feline viral rhinotracheitis and feline caliciviral disease vaccines with live-modified viral vaccines, Feline Pract. (1978) 8:35-42.
108. Povey R.C., A review of feline viral rhinotracheitis (feline herpesvirus I infection), Comp. Immunol. Microbiol. Infect. Dis. (1979) 2:373-387.
109. Povey R.C., Koonse H., Hays M.B., Immunogenicity and safety of an inactivated vaccine for the prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats, J. Am. Vet. Med. Assoc. (1980) 177:347-350.
110. Reubel G.H., Hoffmann D.E., Pedersen N.C., Acute and chronic faucitis of domestic cats: a feline calicivirus induced disease, Vet. Clin. North Am. Small Anim. Pract. (1992) 22:1347-1360.
111. Reubel G.H., Ramos R.A., Hickman M.A., Rimstad E., Hoffmann D.E., Pedersen N.C., Detection of active and latent feline herpesvirus 1 infections using the polymerase chain reaction, Arch. Virol. (1993) 132:409-420.
112. Richards J., Rodan I., Elson T., Flemming D., Ford F., Henry S., Hustead D., Lappin M., Paul M., Rosen D., Scherk M., Scott F., Welborn L., 2000 Report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines, J. Feline Med. Surg. (2001) 3:47-72.
113. Richards J.R., Elston T.H., Ford R.B., Gaskell R.M., Hartmann K., Hurley K.F., Lappin M.R., Levy J.K., Rodan I., Scherk M., Schultz R.D., Sparkes A.H., The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report, J. Am. Vet. Med. Assoc. (2006) 229:1405-1441.
114. Sandmeyer L.S., Keller C.B., Bienzle D., Effects of cidofovir on cell death and replication of feline herpesvirus-1 in cultured feline corneal epithelial cells, Am. J. Vet. Res. (2005) 66:217-222.
115. Sandmeyer L.S., Keller C.B., Bienzle D., Effects of interferon-alpha on cytopathic changes and titers for feline herpesvirus-1 in primary cultures of feline corneal epithelial cells, Am. J. Vet. Res. (2005) 66:210-216.
116. Scott F.W., Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine, Am. J. Vet. Res. (1977) 38:229-234.
117. Scott F.W., Virucidal disinfectants and feline viruses, Am. J. Vet. Res. (1980) 41:410-414.
118. Scott F.W., Geissinger C.M., Long-term immunity in cats vaccinated with an inactivated trivalent vaccine, Am. J. Vet. Res. (1999) 60:652-658.
119. Shields R.P., Gaskin J.M., Fatal generalized feline viral rhinotracheitis in a young adult cat, J. Am. Vet. Med. Assoc. (1977) 170:439-441.
120. Spatz S.J., Rota P.A., Maes R.K., Identification of the feline herpesvirus type 1 (FHV-1) genes encoding glycoproteins G, D, I and E: expression of FHV-1 glycoprotein D in vaccinia and raccoon poxviruses, J. Gen. Virol. (1994) 75:1235-1244.
121. Spencer J.A., Morkel P., Serological survey of sera from survey from lion in Etosha National Park, South Afr. J. Wildl. Res. (1993) 23:60-61.
122. Spradbrow P.B., Carlisle C., Watt D.A., The association of a herpesvirus with generalised disease in a kitten, Vet. Rec. (1971) 89:542-544.
123. Stiles J., Treatment of cats with ocular disease attributable to herpesvirus infection: 17 cases (1983-1993), J. Am. Vet. Med. Assoc. (1995) 207:599-603.
124. Stiles J., McDermott M., Bigsby D., Willis M., Martin C., Roberts W., Greene C., Use of nested polymerase chain reaction to identify feline herpesvirus in ocular tissue from clinically normal cats and cats with corneal sequestra or conjunctivitis, Am. J. Vet. Res. (1997) 58:338-342.
125. Stiles J., McDermott M., Willis M., Roberts W., Greene C., Comparison of nested polymerase chain reaction, virus isolation, and fluorescent antibody testing for identifying feline herpesvirus in cats with conjunctivitis, Am. J. Vet. Res. (1997) 58:804-807.
126. Stiles J., Feline herpesvirus, Vet. Clin. North Am. Small Anim. Pract. (2000) 30:1001-1014.
127. Stiles J., Townsend W.M., Rogers Q.R., Krohne S.G., Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats, Am. J. Vet. Res. (2002) 63:99-103.
128. Stiles J., Feline herpesvirus, Clin. Tech. Small Anim. Pract. (2003) 18:178-185.
129. Sussman M.D., Maes R.K., Kruger J.M., Spatz S.J., Venta P.J., A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis, Virology (1995) 214:12-20.
130. Sussman M.D., Maes R.K., Kruger J.M., Vaccination of cats for feline rhinotracheitis results in a quantitative reduction of virulent feline herpesvirus-1 latency load after challenge, Virology (1997) 228:379-382.
131. Sykes J.E., Browning G.F., Anderson G., Studdert V.P., Smith H.V., Differential sensitivity of culture and the polymerase chain reaction for detection of feline herpesvirus 1 in vaccinated and unvaccinated cats, Arch. Virol. (1997) 142:65-74.
132. Sykes J.E., Anderson G.A., Studdert V.P., Browning G.F., Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease, J. Vet. Intern. Med. (1999) 13:153-162.
133. Tenorio A.P., Franti C.E., Madewell B.R., Pedersen N.C., Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses, Vet. Immunol. Immunopathol. (1991) 29:1-14.
134. Tham K.M., Studdert M.J., Clinical and immunological responses of cats to feline herpesvirus type 1 infection, Vet. Rec. (1987) 120:321-326.
135. Thompson N.L., Sabine M., Hyne R.H., Herpesviruses isolated from cheetahs, Aust. Vet. J. (1971) 47:458.
136. Thompson R.R., Wilcox G.E., Clark W.T., Jansen K.L., Association of calicivirus infection with chronic gingivitis and pharyngitis in cats, J. Small Anim. Pract. (1984) 25:207-210.
137. Townsend W.M., Stiles J., Guptill-Yoran L., Krohne S.G., Development of a reverse transcriptase-polymerase chain reaction assay to detect feline herpesvirus-1 latency-associated transcripts in the trigeminal ganglia and corneas of cats that did not have clinical signs of ocular disease, Am. J. Vet. Res. (2004) 65:314-319.
138. Van der Meulen K., Garre B., Croubels S., Nauwynck H., In vitro comparison of antiviral drugs against feline herpesvirus 1, BMC Vet. Res. (2006) 2:13.
139. Van Pelt C.S., Crandell R.A., Pancreatitis associated with a feline herpesvirus infection, Comp. Anim. Pract. (1987) 1:7.
140. Van Vuuren M., Goosen T., Rogers P., Feline herpesvirus infection in a group of semi-captive cheetahs, J. S. Afr. Vet. Assoc. (1999) 70:132-134.
141. Vogtlin A., Fraefel C., Albini S., Leutenegger C.M., Schraner E., Spiess B., Lutz H., Ackermann M., Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR, J. Clin. Microbiol. (2002) 40:519-523.
142. Volopich S., Benetka V., Schwendenwein I., Mostl K., Sommerfeld-Stur I., Nell B., Cytologic findings, and feline herpesvirus DNA and Chlamydophila felis antigen detection rates in normal cats and cats with conjunctival and corneal lesions, Vet. Ophthalmol. (2005) 8:25-32.
143. Walton T.E., Gillespie J.H., Feline viruses. VII. Immunity to the feline herpesvirus in kittens inoculated experimentally by the aerosol method, Cornell Vet. (1970) 60:232-239.
144. Wardley R.C., Berlinski P.J., Thomsen D.R., Meyer A.L., Post L.E., The use of feline herpesvirus and baculovirus as vaccine vectors for the gag and env genes of feline leukaemia virus, J. Gen. Virol. (1992) 73:1811-1818.
145. Waters L., Hopper C.D., Gruffydd-Jones T.J., Harbour D.A., Chronic gingivitis in a colony of cats infected with feline immunodeficiency virus and feline calicivirus, Vet. Rec. (1993) 132:340-342.
146. Weigler B.J., Babineau C.A., Sherry B., Nasisse M.P., High sensitivity polymerase chain reaction assay for active and latent feline herpesvirus-1 infections in domestic cats, Vet. Rec. (1997) 140:335-338.
147. Weigler B.J., Guy J.S., Naisse M.P., Hancock S.I., Sherry B., Effect of a live attenuated intranasal vaccine on latency and shedding of feline herpesvirus 1 in domestic cats, Arch. Virol. (1997) 142:2389-2400.
148. Weiss R.C., Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication, Am. J. Vet. Res. (1989) 50:1672-1677.
149. Willemse M.J., Chalmers W.S., Cronenberg A.M., Pfundt R., Strijdveen I.G., Sondermeijer P.J., The gene downstream of the gC homologue in feline herpes virus type 1 is involved in the expression of virulence, J. Gen. Virol. (1994) 75:3107-3116.
150. Willemse M.J., Genetically modified feline herpesvirus for oronasal vaccination of cats, 1996, Ph.D. thesis, University of Utrecht.
151. Willemse M.J., Chalmers W.S., Sondermeijer P.J., In vivo properties of a feline herpesvirus type 1 mutant carrying a lacZ insertion at the gI locus of the unique short segment, Vaccine (1996) 14:1-5.
152. Williams D.L., Robinson J.C., Lay E., Field H., Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations, Vet. Rec. (2005) 157:254-257.
153. Willoughby K., Bennett M., Williams R.A., McCracken C., Gaskell R.M., Sequences of the ribonucleotide reductase-encoding genes of felid herpesvirus 1 and molecular phylogenetic analysis, Virus Genes (1997) 15:203-218.
154. Willoughby K., Bennett M., McCracken C.M., Gaskell R.M., Molecular phylogenetic analysis of felid herpesvirus 1, Vet. Microbiol. (1999) 69:93-97.
155. Wilson J.S., Glodt E.G., Koonse H.J., Evaluation of an inactivated feline rhinotracheitis - calicivirus - panleukopenia vaccine for potency and safety, Vet. Med. Small Anim. Clin. (1983) 1869-1874.
156. Yokoyama N., Maeda K., Kawaguchi Y., Ono M., Tohya Y., Mikami T., Construction of the recombinant feline herpesvirus type 1 deleted thymidine kinase gene, J. Vet. Med. Sci. (1995) 57:709-714.
157. Yokoyama N., Maeda K., Fujita K., Ishiguro S., Sagawa T., Mochizuki M., Tohya Y., Mikami T., Vaccine efficacy of recombinant feline herpesvirus type I expressing immunogenic proteins of feline calicivirus in cats, Arch. Virol. (1996) 141:2339-2351.
158. Yokoyama N., Maeda K., Tohya Y., Kawaguchi Y., Fujita K., Mikami T., Recombinant feline herpesvirus type I expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats, Vaccine (1996) 14:1657-1663.
159. Yokoyama N., Fujita K., Damiani A., Sato E., Kurosawa K., Miyazawa T., Ishiguro S., Mochizuki M., Maeda K., Mikami T., Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen, J. Vet. Med. Sci. (1998) 60:717-723.